|
Pioneering advances in biotechnology research and innovation have radically changed health care and opened a gateway to medicines and vaccines for debilitating and life threatening diseases. Pharma IQ looks at 10 leaders, investors, innovators and commentators who are shaping the industry and ushering in a new era of medicine.... Full Whitepaper » |
-
What is an ELN? by Michael Elliott Watch Now »
-
Taking EDC to the next level: Moving from point solutions to an eClinical ecosystem Watch Now »
-
Drive Successful Commercial Product Launches through Effective Key Packaging Watch Now »
-
Pharmaceutical Intellectual Property Rights Webinar Watch Now »
-
Follow Good Weighing Practice™ (GWP®), the Global Weighing Standard, and learn about Accurate Weighing in the Pharmaceutical Industry Watch Now »
- Merck's Executive Director Christine Brideau on How to Address Biological Sample Management in the Discovery Space 6/18/2013
- The Future of the Connected Lab: Features vs. Integration 6/18/2013
- How To: Scalable Unique Device Identification (UDI) Implementation – Real World Lessons Learnt 6/17/2013
- Points of View: Resource Pack for Compound Management 6/14/2013
- Lifting the Veil of Uncertainty: UDIs for Medical Devices 6/14/2013
- Out on a LIM: Is LIMS Selection Becoming Easier? 6/13/2013
Cold Chain - Qualification vs. Validation
Contributor: Benjamin RomeroPosted: 6/13/2013
|
The nomenclature used for describing testing of cold chain packaging used to demonstrate its performance is somewhat controversial. Here we discuss Qualification and Validation, the two most popular terms used to describe such testing. Full Article » |
MHRA Update on the Requirements of Licensed Facilities for Handling 2-8°C Products
Contributor: Ian HollowayPosted: 5/29/2013
Ian Holloway, Senior Pharmaceutical Assessor for the MHRA, discusses updates on new license requirements for 2-8°C handling, expectations for handling and storage facilities and the impact of these updates for CRT products Full Video » |
The Future of the Connected Lab: Features vs. Integration
Contributor: Michael ElliottPosted: 6/18/2013
|
In this exclusive Pharma IQ Interview Michael Elliott, CEO, Atrium Research and Eva-Lotta Westberg, Program Manager, AstraZeneca, discuss what vendors could be doing better to support interoperability, features vs. integration and the biggest challenges for an integration project. Westberg also shares key lessons learnt from embarking on an integration project and her future insights for the connected lab. Full Podcast » |
Points of View: Resource Pack for Compound Management
Posted: 6/14/2013At the Compound & Sample Management Summit in London this May, we interviewed our speakers to get a grasp of what the current trends are in compound management and where it is going. From controlled substances to the merits of different screening techniques and from integrating biologics to the quality of compound libraries, a wide variety of topics is covered in our Compound Management Resource Pack Full Whitepaper » |
-
4th Annual Pharmacovigilance Asia 2013
June 18-21, 2013,
Amara Hotel, Singapore -
Global Pharmaceutical Contract Manufacturing - Jun 2013
June 25-27, 2013,
Thistle Marble Arch , London, United Kingdom -
HR Tech Summit 2013
June 25-26, 2013,
The Millennium Knickerbocker Hotel, Chicago, IL
|
|
i want a job in pharmaceutical labs ...which companies available for females? |
Posted by: munar.pathan | Answer this question
|
|
i want a job in pharmaceutical labs ...which companies available for females? |
Posted by: munar.pathan | Answer this question
|
|
i want a job in pharmaceutical labs ...which companies available for females? |
Posted by: munar.pathan | Answer this question
|
|
what is the total size of bangladesh pharma market? |
Posted by: nayna1265@gmail.com | Answer this question
|
|
Is it possible with a MEG (Magnetoencephalography) to measure the neural activitu or the VLPO (neuron firings)? |
Posted by: Insomnia | Answer this question
|
|
what is the total size of bangladesh pharma market? |
Posted by: nayna1265@gmail.com | Answer this question
Andrea Charles |
About Pharma IQ
Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical and biotechnology professionals with knowledge, information and biotechnology articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical and biotech community.
|




















Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!